|
PPAR- ligands | Type
of cells/organisms | Effects | Ref. |
|
RGZ | In vitro | | |
Glioblastoma U87 | VEGF↓ | [57] |
Lewis lung carcinoma | VEGF↓ | [57] |
Pancreatic tumor AsPC-1 cells | tPA↓ | [58] |
Human breast cancer cell line MDA-MB- | TIMP-1↑ | [59] |
231 | gelatinases↓ | |
Transformed human endometrial cells | VEGF↓ | [60] |
(transiently transfected Ishikawa
cells) | | |
Human anaplastic thyroid carcinoma cells | invasive potential↓ | [61] |
MSA, IAA, ROA, K119, KOA-2 | | |
In vivo | | |
Chick chorioallantoic membrane | Choroidal | [57] |
| neovascularization↓ | |
| C57/BL6 xenografted with 253J B-v | Neovascularization↓ | [62] |
| bladder tumor cells | EC apoptosis↑ | |
|
TGZ | In vitro | | |
Human non small cell lung | ELR + CXC | [63] |
cancer cells A459 | chemokines↓ | |
In vivo | | |
C57/BL6 xenografted with 253J B-v | Neovascularization↓ | [62] |
bladder tumor cells | EC apoptosis↑ | |
|
CGZ | In vitro | | |
Human non-small-cell lung carcinoma | PGE2, COX-2↓ | [64] |
A427 and A549 cell | | |
Human ovarian cancer cells OVCAR-2, | VEGF, PGE2↓ | [65] |
DISS | | |
In vivo | | |
BALB/c nu/nu mice xenografted with | VEGF, PGE2↓ | [65] |
OVCAR-2 or DISS | | |
|
PGZ | In vitro | | |
Renal cell carcinoma cells SMKT-R-1, -2, | VEGF, bFGF↓ | [66] |
-3, -4 | | |
Human non small cell lung | ELR + CXC | [63] |
cancer cells A459 | chemokines↓ | |
Human anaplastic thyroid carcinoma cells | invasive potential↓ | [61] |
MSA, IAA, ROA, K119 and KOA-2 | | |
|
15d-PGJ2 | In vitro | | |
Renal cell carcinoma SMKT-R-1, -2, -3, -4 | VEGF, bFGF↓ | [66] |
Human gastric cancer | Ang-1↓ | [67] |
cells MKN45 | | |
Human PC-3 cells | VEGF↑ | [68] |
Human 5637 urinary bladder cells | VEGF↑ | [68] |
Human breast MCF-7 cells | VEGF↑ | [69] |
Human anaplastic thyroid carcinoma cells | invasive potential↓ | [61] |
MSA, IAA, ROA, K119, KOA-2 | | |
Human pancreatic cancer cells BxPC-3 | MMP-2, -9↓ | [70] |
Transformed human endometrial cells | VEGF↓ | [60] |
(transiently transfected Ishikawa
cells) | | |
In vivo | | |
C57/BL6 xenografted with 253J B-v | Neovascularization↓ | [62] |
bladder tumor cells | EC apoptosis↑ | |
|
RS5444 | In vitro | | |
Human anaplastic thyroid carcinoma cells | CD31↓ | [71] |
DRO90-1, ARO81 | | |
In vivo | | |
Nude mice xenografted with DRO90-1 or | CD31↓ | [71] |
ARO81 tumor cells | | |
|
RS1303 | In vitro | | |
Human anaplastic thyroid carcinoma cells | Invasive potential↓ | [61] |
MSA, IAA, ROA, K119, KOA-2 | | |
|
Nimesulide | In vitro | | |
Human pancreatic cancer cells BxPC-3 | VEGF↑ | [72] |
and MIA PaCa-2 | | |
|